Introduction: Who Should Seek Diagnostic Evaluation

Parents and doctors should consider diagnostic evaluation for congenital pseudarthrosis if a child shows certain warning signs in their leg. This condition typically becomes noticeable either at birth or within the first two years of life, though some cases may appear later during childhood.^[1]

Children who should undergo diagnostic testing include those born with a visible bowing or curving of the lower leg, particularly when the shin bone curves outward and forward. This distinctive shape can be seen even without injury. Additionally, any child who experiences a shin bone fracture from minor trauma or seemingly without cause should be evaluated, especially if the fracture does not heal as expected.^[2]

Early diagnostic evaluation is particularly important for children already diagnosed with neurofibromatosis type 1, a genetic condition affecting nerve tissue growth. Between 40 and 80 percent of children with congenital pseudarthrosis also have neurofibromatosis, making screening especially important in this population. Children with neurofibromatosis who are considered high risk may receive screening X-rays in early childhood even before symptoms appear.^[1][2]

Parents should seek medical attention if they notice their child’s leg appears shorter than the other, if there is obvious bowing of the lower leg, or if their child experiences a fracture with minimal or no trauma. When a child begins walking, parents might notice limping or difficulty bearing weight on the affected leg.^[6]

Classic Diagnostic Methods

Physical Examination

The diagnostic process begins with a thorough physical examination by an orthopedic specialist. During this examination, the doctor carefully inspects the child’s entire body, not just the affected leg. Because congenital pseudarthrosis is strongly associated with neurofibromatosis type 1, doctors perform a comprehensive skin examination looking for distinctive signs of this genetic disorder. They check areas like the underarms and groin for freckling patterns that might indicate neurofibromatosis.^[2]

The doctor examines both legs to compare them, checking for differences in length, shape, and function. They measure the range of motion in the hips, knees, and ankles to understand how well the joints move. The examination includes assessing the alignment of both lower legs and checking for any visible bowing or deformity. The doctor also examines the area of concern to determine if there is mobility at the fracture site, which would indicate the presence of a false joint rather than solid, stable bone.^[2]

An important part of the physical examination involves taking a detailed medical history. The doctor asks about any previous fractures, how they occurred, and whether they healed normally. They inquire about family history of bone conditions or neurofibromatosis. Understanding when symptoms first appeared and how they have progressed helps doctors determine the stage and severity of the condition.^[2]

X-Ray Imaging

X-rays serve as the primary imaging tool for diagnosing congenital pseudarthrosis of the tibia. These images reveal the internal structure of the bone and show whether the bone is intact, bowed, or fractured. X-rays can display the characteristic forward and outward bowing of the tibia that marks this condition. They also show whether a fracture has occurred and, if so, whether it has healed or remains as a non-union.^[2][12]

The X-ray examination includes images of the entire lower leg to assess both the tibia and the smaller bone beside it called the fibula. In 60 to 90 percent of cases, abnormalities are present in the fibula as well as the tibia. X-rays help determine the quality of the bone, showing whether it appears thin, weak, or contains cystic areas that make it prone to breaking.^[1]

Through X-ray imaging, doctors can measure the amount of limb length difference between the two legs, which commonly occurs with this condition. The images also reveal the condition of the nearby joints, including the ankle and knee, which may be affected by the bone deformity. X-rays show the severity of any angular deformity, meaning how much the bone curves away from its normal straight position.^[2]

Advanced Imaging Techniques

When X-rays do not provide enough information, doctors may order additional imaging studies. A CT scan (computed tomography) creates detailed three-dimensional images of the bone structure. This technology can show the extent of bone abnormalities more clearly than regular X-rays and helps doctors plan surgical treatment. CT scans can reveal the internal architecture of the bone and identify areas of weakness or cystic changes.^[12]

An MRI scan (magnetic resonance imaging) uses magnets and radio waves to create detailed images of both bones and soft tissues. This test can show abnormalities in the membrane covering the bone, called the periosteum, which is abnormal in congenital pseudarthrosis and prevents proper bone healing. MRI scans can also identify any nerve tissue abnormalities associated with neurofibromatosis.^[12]

Genetic Testing

Because of the strong connection between congenital pseudarthrosis and neurofibromatosis type 1, doctors recommend genetic testing through a blood test. This test can identify whether a child has the genetic mutation that causes neurofibromatosis. Confirming or ruling out neurofibromatosis is important because this genetic condition can affect many parts of the body beyond the bones, requiring monitoring and management by multiple specialists.^[2][5]

Genetic counseling often accompanies genetic testing to help families understand the inheritance pattern of neurofibromatosis and the implications for the affected child and future children. A multimodality approach that includes genetic evaluation helps ensure comprehensive care for children with this condition.^[1]

Diagnostics for Clinical Trial Qualification

Some specialized centers conduct clinical trials to test new treatment approaches for congenital pseudarthrosis of the tibia. These research studies have specific criteria that determine which patients can participate. Understanding these diagnostic requirements helps families know whether their child might qualify for enrollment in a clinical trial.^[2]

Clinical trials typically require documentation through X-rays showing the presence and specific characteristics of the pseudarthrosis. Researchers need baseline images that clearly demonstrate the non-healed fracture and any bowing or deformity before treatment begins. These images serve as comparison points to measure whether the experimental treatment achieves bone healing.^[2]

Genetic testing results may be required to confirm whether the child has neurofibromatosis type 1 or whether the congenital pseudarthrosis exists without this genetic condition. Some clinical trials focus specifically on one group or the other, so this distinction affects eligibility. Blood tests verify the genetic status and help researchers understand how different underlying causes might respond to treatment.^[2]

Trial organizers document the child’s medical history in detail, including the age when symptoms first appeared, any previous treatments or surgeries, and whether any fractures have occurred. They measure limb length discrepancy precisely and document the degree of angular deformity. These measurements establish baseline data that researchers use to evaluate treatment success.^[2]

Physical examination findings become part of the qualification assessment. Doctors evaluate the range of motion in the false joint area, assess overall leg function, and document any ankle or foot problems. They measure the child’s growth and developmental milestones to ensure the child can safely participate in the trial.^[2]

Some trials may require specific diagnostic imaging beyond standard X-rays. Advanced imaging studies like CT or MRI scans might be necessary to precisely characterize the bone and soft tissue abnormalities. These detailed images help researchers select patients whose condition matches the study’s focus and ensure that the experimental treatment targets the specific problems present in that child.^[12]

Laboratory tests may be required to assess overall health and ensure the child can safely undergo the experimental treatment. Blood tests check bone metabolism markers, kidney function, and other health indicators. These tests help researchers monitor how the treatment affects the body beyond just the bone healing.^[2]

Regular follow-up diagnostic testing occurs throughout clinical trial participation. Researchers schedule X-rays at specific intervals to document how the bone responds to treatment. They repeat physical examinations and measurements to track changes in limb length, alignment, and function. This ongoing diagnostic monitoring generates the data that researchers need to determine whether the experimental treatment works better than existing options.^[2]